Text and Data Mining valid from 2017-03-17
First Online: 17 March 2017
: A.B., L.G. and N.C. are employees of the Pierre Fabre Research Institute, Toulouse, France, which develops mAbs and ADCs, and has a collaboration agreement with AbbVie for the development of hepatocyte growth factor receptor (HGFR)-specific antibodies and ADCs (ABT-700 and ABBV-399). C.D. has received research funding from Pierre Fabre and Sanofi, and has worked as a consultant for Sanofi and Bristol-Myers Squibb.